Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Franz Peter Barany"'
Autor:
Bengt Lindholm, Xiaomeng Zhang, Zhimin Chen, Abdul Rashid Tony Qureshi, Kristin Danielson, Hideyuki Mukai, Mohamed Suliman, Olof Heimbürger, Jianghua Chen, Peter Stenvinkel, Franz Peter Barany
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Higher mean corpuscular volume (MCV), a measure of the average size of the circulating erythrocyte used for differential diagnosis of anemia or for monitoring macrocytosis, is associated with higher mortality in various clinical s
Autor:
Anna Levin, Angelina Schwarz, Maria Herthelius, Lars Wennberg, Franz Peter Barany, Annette Bruchfeld, Anna Witasp, Annika Wernerson
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS As the most common glomerulonephritis globally, mainly affecting younger adults and one of the most common causes of kidney failure [1], IgA Nephropathy (IgAN) poses an immense impact both on the individual and on the societal lev
Autor:
Kakei Ryu, Zhimin Chen, Abdul Rashid Tony Qureshi, Mohamed Suliman, Franz Peter Barany, Olof Heimbürger, Jianghua Chen, Peter Stenvinkel, Bengt Lindholm
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Atherogenic index of plasma (AIP), a logarithmically transformed ratio of triglyceride (TG)/high-density lipoprotein cholesterol (HDL-C), is a biomarker of dyslipidemia and cardiovascular disease (CVD) risk. However, its applicabi
Autor:
Jim Alkas, Alessandro Bosi, Arvid Sjolander, Franz Peter Barany, Carl-Gustaf Elinder, Edouard Fu, Juan Jesus Carrero
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Little is known about the comparative effects of dipeptidyl peptidase-4 inhibitors (DPP-4i), glucagon-like peptide-1 receptor agonists (GLP-1RAs) or sodium glucose cotransporter-2 inhibitors (SGLT2i) on risk of acute kidney injury
Autor:
Xiejia LI, Zhimin Chen, Abdul Rashid Tony Qureshi, Hideyuki Mukai, Mohamed Suliman, Olof Heimbürger, Franz Peter Barany, Jianghua Chen, Peter Stenvinkel, Bengt Lindholm
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS The Framingham risk score (FRS) was developed to estimate an individual`s risk of coronary heart disease over the next 10 years in the general population by using traditional cardiovascular disease (CVD) risk factors age, sex, sys
Autor:
Alessandro Gasparini, Jung-Im Shin, Franz Peter Barany, Morgan E. Grams, Juan Jesus Carrero, Björn Wettermark, Alessandro Bosi, Yunwen Xu, Alex R. Chang
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Many adverse drug events are preventable, such as those potentially resulting from the prescription of nephrotoxic drugs to persons with chronic kidney disease (CKD). We here quantify the extent of contemporary nephrotoxic medicat
Autor:
Innas Forsal, Abdul Rashid Qureshi, Lu Dai, Peter Stenvinkel, Franz Peter Barany, Ken Iseri, Xin Li, Kristin Danielson, Bengt Lindholm, Olof Heimbürger
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Transferrin saturation (TSAT) is an indicator of iron deficiency or overload, but its relationship with mortality in patients with different stages of chronic kidney disease (CKD) is unclear. We investigated the association of TSA
Autor:
Katarina Hedman, Franz Peter Barany, Marie Evans, Glen James, Juan Jesus Carrero, Yang Xu, Arvid Sjölander
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Attaining the narrow hemoglobin range (10-12 g/dL) recommended by current ERBP renal anemia guidelines may be difficult, and whether this leads to better outcomes is not well known. This study aimed to identify patient and clinica
Autor:
Torkel B. Brismar, Magnus Söderberg, Jonaz Ripsweden, Lu Dai, Bengt Lindholm, Franz Peter Barany, Abdul Rashid Qureshi, Peter Stenvinkel, Leon J. Schurgers
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Vitamin K is a potential protective factor against premature vascular aging and vascular calcification (VC). Whether vitamin K supplement could halt VC progression in patients with end-stage renal disease (ESRD) is not clear, part
Autor:
Ingrid Bergström, Longkai Li, Olof Heimbürger, Ken Iseri, Franz Peter Barany, Torkel B. Brismar, Xin Li, Jonaz Ripsweden, Abdul Rashid Qureshi, Peter Stenvinkel, Bengt Lindholm
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Bone loss is associated with progression of cardiac calcification and increased mortality in end stage renal disease (ESRD) patients but the relations and underlying causes are unclear. We investigated factors associated with chan